Results 31 to 40 of about 3,379 (229)

Effect of Betahistine on Daytime Sedation and Metabolic Parameters in Patients with Schizophrenia on Second-generation Antipsychotics. [PDF]

open access: yesIndian J Psychol Med
Background: Second-generation antipsychotics (SGAs), widely used in the management of schizophrenia, have significant side effects like daytime sedation and metabolic derangement.
Mamidipalli SS   +4 more
europepmc   +2 more sources

Suicidality associated with betahistine: A rare case report and systematic review of histaminergic drug-induced depression. [PDF]

open access: yesMedicine (Baltimore)
Rationale: Drug-induced suicidality is a severe and frequently overlooked area within pharmacovigilance. While the traditional focus has centered on psychotropic medications, non-psychotropic drugs acting on histamine receptors may also induce depression
Tang J, Zeng Y, Jiang X.
europepmc   +2 more sources

An Eco-Friendly N-Doped Carbon Quantum Dot-Based Fluorimetric Assay for Sensitive Betahistine Quantitation in Pharmaceuticals and Biological Fluids. [PDF]

open access: yesLuminescence
A rapid, sensitive, and sustainable fluorimetric method based on fluorescence quenching of nitrogen‐doped carbon quantum dots (N‐CQDs) is introduced for the first time to determine betahistine dihydrochloride (BTH).
Kamel MA   +4 more
europepmc   +2 more sources

Betahistine alleviates benign paroxysmal positional vertigo (BPPV) through inducing production of multiple CTRP family members and activating the ERK1/2-AKT/PPARy pathway

open access: yesBiological Research, 2022
Background Betahistine is a clinical medication for the treatment of benign paroxysmal positional vertigo (BPPV). Otolin, a secreted glycoprotein with a C-terminal globular domain homologous to the immune complement C1q, has been identified as a ...
Jing Hui, Qi Lei, Zhi Ji, Dingjing Zi
doaj   +1 more source

A comparative study on the response to Epley’s maneuver and betahistine dihydrochloride management among patients with benign paroxysmal positional vertigo [PDF]

open access: yesMuthanna Medical Journal, 2021
The objective of this study is to evaluate the effectiveness of Epley’s maneuver and Betahistine dihydrochloride on the improvement of patients from BPPV and to comparing the outcome of the use of Betahistine dihydrochloride with the outcome of the use ...
Zaid I. Alsareeh
doaj   +1 more source

Sustainable fluorescence quenching approach for betahistine analysis: greenness evaluation. [PDF]

open access: yesSci Rep
A simple, sensitive, and eco-friendly spectrofluorimetric method has been developed for the determination of betahistine in bulk powder and tablet formulations.
Attia TZ   +3 more
europepmc   +2 more sources

Effectiveness of intratympanic dexamethasone for the treatment of vertigo attacks in patients with Ménière’s disease compared with betahistine pharmacotherapy

open access: yesJournal of International Medical Research, 2021
Objective This study analyzed the possible effects of intratympanic steroid (ITS) therapy in the symptomatic treatment of vertigo attacks in patients with Ménière’s disease.
András Molnár   +3 more
doaj   +1 more source

Vestibular Drop Attack: An Analysis of the Therapeutic Response

open access: yesAudiology Research, 2023
The present study evaluates the response to betahistine in patients who presented vestibular drops attacks in the context of Ménière’s disease (MD) and the factors that can predict an unfavorable response to it.
Sergio Carmona   +2 more
doaj   +1 more source

Prescribing practices for Betahistine [PDF]

open access: yesBritish Journal of Clinical Pharmacology, 2008
Betahistine dihydrochloride (Serc) is an oral preparation of a histamine precursor marketed in Europe as a specific treatment for Meniere's disease. Its proposed mode of action is to cause vasodilation in ischaemic areas of the stria vascularis and dark cells – the areas implicated in the pathogenesis of Meniere's disease.
John S, Phillips, Peter R, Prinsley
openaire   +2 more sources

Betahistine for symptoms of vertigo [PDF]

open access: yesCochrane Database of Systematic Reviews, 2013
Vertigo is a symptom in which individuals experience a false sensation of movement. This type of dizziness is thought to originate in the inner ear labyrinth or its neural connections. It is a commonly experienced symptom and can cause significant problems with carrying out normal activities.
Murdin, L, Hussain, K, Schilder, AGM
openaire   +3 more sources

Home - About - Disclaimer - Privacy